Elucidation of Resistance Mechanisms to Second-Generation ALK Inhibitors Alectinib and Ceritinib in Non-Small Cell Lung Cancer Cells | |
Dong, Xuyuan; Fernandez-Salas, Ester; Li, Enxiao; Wang, Shaomeng | |
刊名 | NEOPLASIA |
2016 | |
卷号 | 18期号:[db:dc_citation_issue]页码:162-171 |
ISSN号 | 1476-5586 |
DOI | [db:dc_identifier_doi] |
URL标识 | 查看原文 |
WOS记录号 | [DB:DC_IDENTIFIER_WOSID] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3225901 |
专题 | 西安交通大学 |
推荐引用方式 GB/T 7714 | Dong, Xuyuan,Fernandez-Salas, Ester,Li, Enxiao,et al. Elucidation of Resistance Mechanisms to Second-Generation ALK Inhibitors Alectinib and Ceritinib in Non-Small Cell Lung Cancer Cells[J]. NEOPLASIA,2016,18([db:dc_citation_issue]):162-171. |
APA | Dong, Xuyuan,Fernandez-Salas, Ester,Li, Enxiao,&Wang, Shaomeng.(2016).Elucidation of Resistance Mechanisms to Second-Generation ALK Inhibitors Alectinib and Ceritinib in Non-Small Cell Lung Cancer Cells.NEOPLASIA,18([db:dc_citation_issue]),162-171. |
MLA | Dong, Xuyuan,et al."Elucidation of Resistance Mechanisms to Second-Generation ALK Inhibitors Alectinib and Ceritinib in Non-Small Cell Lung Cancer Cells".NEOPLASIA 18.[db:dc_citation_issue](2016):162-171. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论